Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
902 Ergebnisse
| MN1W0X |  | Regeneron Pharmaceuticals Inc./OS/Call [850]/MS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | 900,000 | 70,437 % | - | - | - | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN6F4A | | Regeneron Pharmaceuticals Inc./OS/Call [850]/MS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,966 % | 0,287 | -0,010 | 5,657 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MN8XDL | | Regeneron Pharmaceuticals Inc./OS/Call [850]/MS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | 900,000 | - | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MN8XDM | | Regeneron Pharmaceuticals Inc./OS/Call [850]/MS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | 900,000 | 74,524 % | - | - | - | 20.11.2026 | 0,100 | Morgan Stanley | |
| MN8XDN | | Regeneron Pharmaceuticals Inc./OS/Call [850]/MS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | 900,000 | - | - | - | - | 18.12.2026 | 0,100 | Morgan Stanley | |
| MR3CF6 | | Regeneron Pharmaceuticals Inc./OS/Call [850]/MS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 49,699 % | 0,516 | -0,009 | 2,608 | 16.06.2028 | 0,010 | Morgan Stanley | |
| FD442F | Regeneron Pharmaceuticals Inc./OS/Call [850]/SOC | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,738 % | 0,066 | -0,070 | 15,002 | 18.09.2026 | 0,100 | Société Générale | ||
| FD442J | Regeneron Pharmaceuticals Inc./OS/Call [850]/SOC | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,115 % | 0,180 | -0,092 | 8,428 | 18.12.2026 | 0,100 | Société Générale | ||
| FD48PA | Regeneron Pharmaceuticals Inc./OS/Call [850]/SOC | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,989 % | 0,257 | -0,090 | 6,383 | 19.03.2027 | 0,100 | Société Générale | ||
| FD51EV | Regeneron Pharmaceuticals Inc./OS/Call [850]/SOC | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,780 % | 0,356 | -0,096 | 4,927 | 17.06.2027 | 0,100 | Société Générale | ||
| FE23H8 | Regeneron Pharmaceuticals Inc./OS/Call [850]/SOC | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,505 % | 0,419 | -0,080 | 3,658 | 21.01.2028 | 0,100 | Société Générale | ||
| GW02R9 | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,168 % | 0,367 | -0,009 | 4,199 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02SG | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,453 % | 0,288 | -0,010 | 6,093 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW02UX | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,068 % | 0,321 | -0,009 | 4,970 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW061C | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,835 % | 0,439 | -0,008 | 3,564 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J33 | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,926 % | 0,399 | -0,008 | 3,792 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K3S | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,364 % | 0,431 | -0,009 | 3,646 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K5E | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,100 % | 0,413 | -0,008 | 3,634 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K5F | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,173 % | 0,367 | -0,009 | 4,199 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K8B | Regeneron Pharmaceuticals Inc./OS/Call [860]/GOLDS | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,370 % | 0,321 | -0,009 | 4,943 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| JY3SF1 | Regeneron Pharmaceuticals Inc./OS/Call [860]/JPMD | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,601 % | 0,215 | -0,009 | 7,913 | 15.01.2027 | 0,010 | JP Morgan | ||
| JY3YV3 | Regeneron Pharmaceuticals Inc./OS/Call [860]/JPMD | - | - | 860,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,472 % | 0,254 | -0,009 | 6,335 | 19.03.2027 | 0,010 | JP Morgan | ||
| GW1J0J | Regeneron Pharmaceuticals Inc./OS/Call [870]/GOLDS | - | - | 870,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,757 % | 0,424 | -0,009 | 3,641 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K42 | Regeneron Pharmaceuticals Inc./OS/Call [870]/GOLDS | - | - | 870,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,583 % | 0,360 | -0,009 | 4,196 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K4N | Regeneron Pharmaceuticals Inc./OS/Call [870]/GOLDS | - | - | 870,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,771 % | 0,402 | -0,008 | 3,698 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K55 | Regeneron Pharmaceuticals Inc./OS/Call [870]/GOLDS | - | - | 870,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,948 % | 0,398 | -0,008 | 3,723 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K8D | Regeneron Pharmaceuticals Inc./OS/Call [870]/GOLDS | - | - | 870,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,333 % | 0,308 | -0,009 | 5,011 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| MJ5C6J | | Regeneron Pharmaceuticals Inc./OS/Call [875]/MS | - | - | 875,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,197 % | 0,199 | -0,011 | 7,209 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM7L6R | | Regeneron Pharmaceuticals Inc./OS/Call [875]/MS | - | - | 875,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,039 % | 0,318 | -0,009 | 4,787 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM7L6Q | | Regeneron Pharmaceuticals Inc./OS/Call [875]/MS | - | - | 875,000 | call | Regeneron Pharmaceuticals Inc. | - | 57,537 % | 0,127 | -0,016 | 9,637 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN1HGU | | Regeneron Pharmaceuticals Inc./OS/Call [875]/MS | - | - | 875,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,489 % | 0,442 | -0,010 | 3,353 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6F4B | | Regeneron Pharmaceuticals Inc./OS/Call [875]/MS | - | - | 875,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,246 % | 0,290 | -0,011 | 5,718 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR4HMH | | Regeneron Pharmaceuticals Inc./OS/Call [875]/MS | - | - | 875,000 | call | Regeneron Pharmaceuticals Inc. | - | - | - | - | - | 16.06.2028 | 0,010 | Morgan Stanley | |
| GW02R8 | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,428 % | 0,350 | -0,009 | 4,251 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02S4 | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,360 % | 0,300 | -0,009 | 5,047 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW02SE | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,202 % | 0,234 | -0,009 | 6,375 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0616 | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,100 % | 0,395 | -0,008 | 3,697 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J0D | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,839 % | 0,415 | -0,009 | 3,667 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K4A | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,747 % | 0,385 | -0,008 | 3,781 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K4R | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,127 % | 0,346 | -0,008 | 4,291 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K7B | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,100 % | 0,395 | -0,008 | 3,697 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K9L | Regeneron Pharmaceuticals Inc./OS/Call [880]/GOLDS | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,415 % | 0,300 | -0,009 | 5,042 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| JE0L3A | Regeneron Pharmaceuticals Inc./OS/Call [880]/JPMD | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,536 % | 0,050 | -0,006 | 15,047 | 18.09.2026 | 0,010 | JP Morgan | ||
| JY3YV5 | Regeneron Pharmaceuticals Inc./OS/Call [880]/JPMD | - | - | 880,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,627 % | 0,228 | -0,008 | 6,507 | 19.03.2027 | 0,010 | JP Morgan | ||
| GW1J0E | Regeneron Pharmaceuticals Inc./OS/Call [890]/GOLDS | - | - | 890,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,538 % | 0,376 | -0,008 | 3,829 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K4P | Regeneron Pharmaceuticals Inc./OS/Call [890]/GOLDS | - | - | 890,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,076 % | 0,394 | -0,008 | 3,633 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K4W | Regeneron Pharmaceuticals Inc./OS/Call [890]/GOLDS | - | - | 890,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,889 % | 0,406 | -0,009 | 3,695 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K75 | Regeneron Pharmaceuticals Inc./OS/Call [890]/GOLDS | - | - | 890,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,300 % | 0,339 | -0,008 | 4,305 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K89 | Regeneron Pharmaceuticals Inc./OS/Call [890]/GOLDS | - | - | 890,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,041 % | 0,320 | -0,009 | 4,975 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| PL1GHB | | Regeneron Pharmaceuticals Inc./OS/Call [900]/BNP | - | - | 900,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,054 % | 0,141 | -0,008 | 8,535 | 18.12.2026 | 0,010 | BNP Paribas |